These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 14609484)

  • 1. Threats to validity of observational studies on disease-modifying antirheumatic drug therapies for rheumatoid arthritis: new aspects after the fall of the pyramid and the rise of new therapeutics.
    Aletaha D; Smolen JS
    Curr Rheumatol Rep; 2003 Dec; 5(6):409-12. PubMed ID: 14609484
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there still a role for traditional disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis?
    Cannella AC; O'Dell JR
    Curr Opin Rheumatol; 2003 May; 15(3):185-92. PubMed ID: 12707569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring the efficacy and effectiveness of rheumatoid arthritis therapy: time to change our thinking and adopt a new model.
    Wolfe F; Caplan L; Michaud K
    J Rheumatol; 2004 Dec; 31(12):2317-9. PubMed ID: 15570626
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in the clinical presentation of patients with rheumatoid arthritis from the early 1990s to the years 2010: earlier identification but more severe patient reported outcomes.
    Nieuwenhuis WP; de Wit MP; Boonen A; van der Helm-van Mil AH
    Ann Rheum Dis; 2016 Nov; 75(11):2054-2056. PubMed ID: 27558985
    [No Abstract]   [Full Text] [Related]  

  • 5. Rate of remission among rheumatoid arthritis patients being treated by rheumatologists in routine practice.
    Dubost JJ; Pereira B; Fan A; Soubrier M
    Joint Bone Spine; 2019 Nov; 86(6):799-800. PubMed ID: 30928537
    [No Abstract]   [Full Text] [Related]  

  • 6. Controversies in rheumatoid arthritis glucocorticoid therapy.
    Ruyssen-Witrand A; Constantin A
    Joint Bone Spine; 2018 Jul; 85(4):417-422. PubMed ID: 29246530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proposed treatment algorithm for rheumatoid arthritis: aggressive therapy, methotrexate, and quantitative measures.
    Smolen JS; Sokka T; Pincus T; Breedveld FC
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S209-10. PubMed ID: 14969080
    [No Abstract]   [Full Text] [Related]  

  • 8. DMARD use in early rheumatoid arthritis. Lessons from observations in patients with established disease.
    Aletaha D; Smolen JS
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S169-73. PubMed ID: 14969071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of a rheumatoid arthritis records-based index of severity.
    Ting G; Schneeweiss S; Katz JN; Weinblatt ME; Cabral D; Scranton RE; Solomon DH
    J Rheumatol; 2005 Sep; 32(9):1679-87. PubMed ID: 16142860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiinflammatory effect of simvastatin in patients with rheumatoid arthritis.
    Kanda H; Hamasaki K; Kubo K; Tateishi S; Yonezumi A; Kanda Y; Yamamoto K; Mimura T
    J Rheumatol; 2002 Sep; 29(9):2024-6. PubMed ID: 12233907
    [No Abstract]   [Full Text] [Related]  

  • 11. RAPID: rheumatoid arthritis.
    Weinblatt ME; Kuritzky L
    J Fam Pract; 2007 Apr; 56(4 Suppl):S1-7; quiz S8. PubMed ID: 17403322
    [No Abstract]   [Full Text] [Related]  

  • 12. Current tumor necrosis factor-alpha inhibitor use is associated with a higher probability of remissions in patients with rheumatoid arthritis.
    Liang GC; Cordero M; Dyer A; Chang RW
    J Rheumatol; 2005 Sep; 32(9):1662-5. PubMed ID: 16142857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multi-faceted assessment of independence in patients with rheumatoid arthritis: preliminary validation from the ATTAIN study.
    Hassett AL; Li T; Buyske S; Savage SV; Gignac MA
    Curr Med Res Opin; 2008 May; 24(5):1443-53. PubMed ID: 18402714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Utrecht experience with different treatment strategies in early rheumatoid arthritis.
    Verstappen SM; Jacobs JW; Bijlsma JW;
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S165-8. PubMed ID: 14969070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Earlier time to remission predicts sustained clinical remission in early rheumatoid arthritis--results from the Canadian Early Arthritis Cohort (CATCH).
    Kuriya B; Xiong J; Boire G; Haraoui B; Hitchon C; Pope J; Thorne JC; Tin D; Keystone EC; Bykerk V;
    J Rheumatol; 2014 Nov; 41(11):2161-6. PubMed ID: 25274902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Number of active joints, not diagnosis, is the primary determinant of function and performance in early synovitis.
    Gerber LH; Furst G; Yarboro C; el-Gabalawy H
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S65-70. PubMed ID: 14969053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abatacept therapy in rheumatoid arthritis with interstitial lung disease.
    Mera-Varela A; Pérez-Pampín E
    J Clin Rheumatol; 2014 Dec; 20(8):445-6. PubMed ID: 25417684
    [No Abstract]   [Full Text] [Related]  

  • 18. [Management of severe synovial arthritis with drugs].
    Korpela M
    Duodecim; 2004; 120(6):707-14. PubMed ID: 15119232
    [No Abstract]   [Full Text] [Related]  

  • 19. Flare Rate in Patients with Rheumatoid Arthritis in Low Disease Activity or Remission When Tapering or Stopping Synthetic or Biologic DMARD: A Systematic Review.
    Kuijper TM; Lamers-Karnebeek FB; Jacobs JW; Hazes JM; Luime JJ
    J Rheumatol; 2015 Nov; 42(11):2012-22. PubMed ID: 26428204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rheumatoid arthritis: early detection - early treatment. Lasting remission: a realistic therapy goal].
    Stiefelhagen P
    MMW Fortschr Med; 2011 Jun; 153(23):14-7. PubMed ID: 21692213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.